Changes in brain protein expression are linked to magnesium restriction-induced depression-like behavior

Amino Acids

Volumn 40, Issue 4, 2011, Pages 1231-1248

  Whittle, Nigel ^a,b   Li, Lin ^b   Chen, Wei Qiang ^b   Yang, Jae Won ^b   Sartori, Simone B ^a   Lubec, Gert ^b   Singewald, Nicolas ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Amygdala; Depression; Gel based proteomics; Hypothalamus; Magnesium restricted diet

Indexed keywords

DIMETHYLARGININASE; DIMETHYLARGININASE 1; GLUTAMATE DEHYDROGENASE; GLUTAMATE DEHYDROGENASE 1; MANGANESE SUPEROXIDE DISMUTASE; NITRIC OXIDE; PAROXETINE; UNCLASSIFIED DRUG; VOLTAGE DEPENDENT ANION CHANNEL 1;

AMYGDALOID NUCLEUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN LEVEL; CONTROLLED STUDY; DEPRESSION; DIET RESTRICTION; DISEASE ASSOCIATION; ENERGY METABOLISM; HYPOTHALAMUS; MAGNESIUM RESTRICTION; MALE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RISK FACTOR;

AMIDOHYDROLASES; AMYGDALA; ANIMALS; ANTIDEPRESSIVE AGENTS; DEPRESSION; DIET; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; GENE EXPRESSION PROFILING; GLUTAMATE DEHYDROGENASE; HYPOTHALAMUS; MAGNESIUM DEFICIENCY; MALE; MICE; MICE, INBRED C57BL; NITRIC OXIDE; OXIDATIVE STRESS; PAROXETINE; PROTEOMICS; SUPEROXIDE DISMUTASE; TANDEM MASS SPECTROMETRY; VOLTAGE-DEPENDENT ANION CHANNEL 1;

MUS;

EID: 79954427252     PISSN: 09394451     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00726-010-0758-1     Document Type: Article

References (89)

1. BM Altura A Gebrewold A Zhang BT Altura RK Gupta 1997 Short-term reduction in dietary intake of magnesium causes deficits in brain intracellular free Mg2+ and [H+]i but not high-energy phosphates as observed by in vivo 31P-NMR Biochim Biophys Acta 1358 1 5 9296515 10.1016/S0167-4889(97)00077-3 1:CAS:528:DyaK2sXlt1Gnurk%3D (Pubitemid 27365968)
2. A Anand A Shekhar 2003 Brain imaging studies in mood and anxiety disorders: special emphasis on the amygdala Ann N Y Acad Sci 985 370 388 12724172 10.1111/j.1749-6632.2003.tb07095.x (Pubitemid 36521128)
3. C Astier E Rock C Lab E Gueux A Mazur Y Rayssiguier 1996 Functional alterations in sarcoplasmic reticulum membranes of magnesium-deficient rat skeletal muscle as consequences of free radical-mediated process Free Radic Biol Med 20 667 674 8721613 10.1016/0891-5849(95)02180-9 1:CAS:528: DyaK28XisVWjur0%3D
4. CP Baines RA Kaiser T Sheiko WJ Craigen JD Molkentin 2007 Voltage-dependent anion channels are dispensable for mitochondrial-dependent cell death Nat Cell Biol 9 550 555 17417626 10.1038/ncb1575 1:CAS:528: DC%2BD2sXkslyiur8%3D (Pubitemid 46696536)
5. Banki CM, Vojnik M, Papp Z et al (1985) Cerebrospinal fluid magnesium and calcium related to amine metabolites, diagnosis, and suicide attempts. Biol Psychiatry 20:163-171 (Pubitemid 16051868)
6. CL Beasley K Pennington A Behan R Wait MJ Dunn D Cotter 2006 Proteomic analysis of the anterior cingulate cortex in the major psychiatric disorders: evidence for disease-associated changes Proteomics 6 3414 3425 16637010 10.1002/pmic.200500069 1:CAS:528:DC%2BD28Xmt1artLY%3D (Pubitemid 43886157)
7. MF Belin M Didier-Bazes H Akaoka H Hardin-Pouzet A Bernard P Giraudon 1997 Changes in astrocytic glutamate catabolism enzymes following neuronal degeneration or viral infection Glia 21 154 161 9298858 10.1002/(SICI)1098- 1136(199709)21:1<154::AID-GLIA17>3.0.CO;2-R 1:STN:280:DyaK2svkt1ejuw%3D%3D (Pubitemid 27389651)
8. M Bourin P Chue Y Guillon 2001 Paroxetine: a review CNS Drug Rev 7 25 47 11420571 10.1111/j.1527-3458.2001.tb00189.x 1:CAS:528:DC%2BD3MXjtVyitLk%3D (Pubitemid 32280682)
9. Burgos M, Fradejas N, Calvo S, Kang SU, Tranque P, Lubec G (2010) A proteomic analysis of PKCepsilon targets in astrocytes: implications for astrogliosis. Amino Acids (in press)
10. L Bussiere A Mazur E Gueux W Nowacki Y Rayssiguier 1995 Triglyceride-rich lipoproteins from magnesium-deficient rats are more susceptible to oxidation by cells and promote proliferation of cultured vascular smooth muscle cells Magnes Res 8 151 157 7547176 1:CAS:528:DyaK2MXms1CiurY%3D
11. L Carboni C Piubelli C Pozzato H Astner R Arban PG Righetti M Hamdan E Domenici 2006 Proteomic analysis of rat hippocampus after repeated psychosocial stress Neuroscience 137 1237 1246 16338082 10.1016/j.neuroscience.2005.10.045 1:CAS:528:DC%2BD28Xos1elsQ%3D%3D (Pubitemid 43133149)
12. L Carboni M Vighini C Piubelli L Castelletti A Milli E Domenici 2006 Proteomic analysis of rat hippocampus and frontal cortex after chronic treatment with fluoxetine or putative novel antidepressants: CRF1 and NK1 receptor antagonists Eur Neuropsychopharmacol 16 521 537 16517129 10.1016/j.euroneuro. 2006.01.007 1:CAS:528:DC%2BD28XpsVWlt7k%3D (Pubitemid 44376555)
13. EH Cheng TV Sheiko JK Fisher WJ Craigen SJ Korsmeyer 2003 VDAC2 inhibits BAK activation and mitochondrial apoptosis Science 301 513 517 12881569 10.1126/science.1083995 1:CAS:528:DC%2BD3sXls1Cqsr4%3D (Pubitemid 36900308)
14. JA Cowan 2002 Structural and catalytic chemistry of magnesium-dependent enzymes Biometals 15 225 235 12206389 10.1023/A:1016022730880 1:CAS:528:DC%2BD38XkvFCgtLs%3D (Pubitemid 34816207)
15. F Crespi 2010 The selective serotonin reuptake inhibitor fluoxetine reduces striatal in vivo levels of voltammetric nitric oxide (NO): a feature of its antidepressant activity? Neurosci Lett 470 95 99 20036714 10.1016/j.neulet.2009.12.049 1:CAS:528:DC%2BC3cXhtVKitLk%3D
16. JF Cryan A Markou I Lucki 2002 Assessing antidepressant activity in rodents: recent developments and future needs Trends Pharmacol Sci 23 238 245 12008002 10.1016/S0165-6147(02)02017-5 1:CAS:528:DC%2BD38XjsVWjsbo%3D (Pubitemid 34465544)
17. WC Drevets 2003 Neuroimaging abnormalities in the amygdala in mood disorders Ann N Y Acad Sci 985 420 444 12724175 10.1111/j.1749-6632.2003. tb07098.x (Pubitemid 36521131)
18. RS Duman GR Heninger EJ Nestler 1997 A molecular and cellular theory of depression Arch Gen Psychiatry 54 597 606 9236543 1:CAS:528:DyaK2sXltFCit7g%3D (Pubitemid 27306570)
19. RS Duman J Malberg J Thome 1999 Neural plasticity to stress and antidepressant treatment Biol Psychiatry 46 1181 1191 10560024 10.1016/S0006-3223(99)00177-8 1:CAS:528:DyaK1MXotVOktr0%3D (Pubitemid 30114436)
20. GA Eby KL Eby 2006 Rapid recovery from major depression using magnesium treatment Med Hypotheses 67 362 370 16542786 10.1016/j.mehy.2006.01.047 1:CAS:528:DC%2BD28XltlelsrY%3D (Pubitemid 43825609)
21. N Elizalde FJ Gil-Bea MJ Ramirez B Aisa B Lasheras J Del Rio RM Tordera 2008 Long-lasting behavioral effects and recognition memory deficit induced by chronic mild stress in mice: effect of antidepressant treatment Psychopharmacology (Berl) 199 1 14 10.1007/s00213-007-1035-1 1:CAS:528:DC%2BD1cXnvVKgs74%3D
22. Y Ergun UG Ergun 2007 Prevention of pro-depressant effect of L-arginine in the forced swim test by NG-nitro-L-arginine and [1H-[1, 2, 4]Oxadiazole[4, 3-a]quinoxalin-1-one] Eur J Pharmacol 554 150 154 17125765 10.1016/j.ejphar. 2006.09.067 (Pubitemid 44879408)
23. MS Finkel F Laghrissi-Thode BG Pollock J Rong 1996 Paroxetine is a novel nitric oxide synthase inhibitor Psychopharmacol Bull 32 653 658 8993087 1:CAS:528:DyaK2sXjtFejtw%3D%3D (Pubitemid 26428269)
24. AM Freedman MM Cassidy WB Weglicki 1991 Magnesium-deficient myocardium demonstrates an increased susceptibility to an in vivo oxidative stress Magnes Res 4 185 189 1799553 1:CAS:528:DyaK38Xhslaku70%3D
25. AM Freedman IT Mak RE Stafford BF Dickens MM Cassidy RA Muesing WB Weglicki 1992 Erythrocytes from magnesium-deficient hamsters display an enhanced susceptibility to oxidative stress Am J Physiol 262 C1371 C1375 1319674 1:CAS:528:DyaK38XltV2gtbc%3D
26. F Frigerio M Casimir S Carobbio P Maechler 2008 Tissue specificity of mitochondrial glutamate pathways and the control of metabolic homeostasis Biochim Biophys Acta 1777 965 972 18486589 10.1016/j.bbabio.2008.04.031 1:CAS:528:DC%2BD1cXnsFClsrY%3D
27. P Galan P Preziosi V Durlach P Valeix L Ribas D Bouzid A Favier S Hercberg 1997 Dietary magnesium intake in a French adult population Magnes Res 10 321 328 9513928 1:CAS:528:DyaK1cXit1egsLc%3D (Pubitemid 127525893)
28. AM Gardier DJ David G Jego C Przybylski C Jacquot S Durier B Gruwez E Douvier P Beauverie N Poisson R Hen M Bourin 2003 Effects of chronic paroxetine treatment on dialysate serotonin in 5-HT1B receptor knockout mice J Neurochem 86 13 24 12807420 10.1046/j.1471-4159.2003.01827.x 1:CAS:528:DC%2BD3sXltFeltb0%3D (Pubitemid 36753841)
29. L Garfinkel D Garfinkel 1985 Magnesium regulation of the glycolytic pathway and the enzymes involved Magnesium 4 60 72 2931560 1:CAS:528: DyaL2MXmtVyqtLw%3D
30. German-Fattal M, Lecerf F, Sabbagh F, Maurois P, Durlach J, Bac P(2008) Neuroprotective gene profile in the brain of magnesium-deficient mice. Biomed Pharmacother 62:264-272 (Pubitemid 351626448)
31. C Giulivi A Boveris E Cadenas 1995 Hydroxyl radical generation during mitochondrial electron transfer and the formation of 8-hydroxydesoxyguanosine in mitochondrial DNA Arch Biochem Biophys 316 909 916 7864650 10.1006/abbi.1995. 1122 1:CAS:528:DyaK2MXjs1OjsrY%3D
32. E Gueux C Cubizolles L Bussiere A Mazur Y Rayssiguier 1993 Oxidative modification of triglyceride-rich lipoproteins in hypertriglyceridemic rats following magnesium deficiency Lipids 28 573 575 8355585 10.1007/BF02536092 1:CAS:528:DyaK3sXkvFChur4%3D (Pubitemid 23177658)
33. H Hackbarth N Kuppers W Bohnet 2000 Euthanasia of rats with carbon dioxide-animal welfare aspects Lab Anim 34 91 96 10759372 10.1258/ 002367700780578055 1:STN:280:DC%2BD3c3itFWhtA%3D%3D (Pubitemid 30060266)
34. JJ Haddad 2005 N-methyl-D-aspartate (NMDA) and the regulation of mitogen-activated protein kinase (MAPK) signaling pathways: a revolving neurochemical axis for therapeutic intervention? Prog Neurobiol 77 252 282 16343729 1:CAS:528:DC%2BD2MXhtlWqurrP (Pubitemid 41790443)
35. A Harkin TJ Connor MP Burns JP Kelly 2004 Nitric oxide synthase inhibitors augment the effects of serotonin re-uptake inhibitors in the forced swimming test Eur Neuropsychopharmacol 14 274 281 15163436 10.1016/j.euroneuro. 2003.08.010 1:CAS:528:DC%2BD2cXktF2ktLg%3D (Pubitemid 38649083)
36. T Hattori N Takei Y Mizuno K Kato S Kohsaka 1995 Neurotrophic and neuroprotective effects of neuron-specific enolase on cultured neurons from embryonic rat brain Neurosci Res 21 191 198 7753500 10.1016/0168-0102(94)00849-B 1:CAS:528:DyaK2MXkslGju7Y%3D
37. M Hayashi 2009 Oxidative stress in developmental brain disorders Neuropathology 29 1 8 19154320 10.1111/j.1440-1789.2008.00888.x
38. H Husi SG Grant 2001 Proteomics of the nervous system Trends Neurosci 24 259 266 11311377 10.1016/S0166-2236(00)01792-6 1:CAS:528:DC%2BD3MXislGnsbs%3D (Pubitemid 32304467)
39. SY Inan I Yalcin F Aksu 2004 Dual effects of nitric oxide in the mouse forced swimming test: possible contribution of nitric oxide-mediated serotonin release and potassium channel modulation Pharmacol Biochem Behav 77 457 464 15006455 10.1016/j.pbb.2003.12.024 1:CAS:528:DC%2BD2cXhvVyhtbg%3D (Pubitemid 38296804)
40. DV Iosifescu PE Renshaw 2003 31P-magnetic resonance spectroscopy and thyroid hormones in major depressive disorder: toward a bioenergetic mechanism in depression? Harv Rev Psychiatry 11 51 63 12868506 10.1080/10673220303959 (Pubitemid 36407107)
41. DV Iosifescu NR Bolo AA Nierenberg JE Jensen M Fava PF Renshaw 2008 Brain bioenergetics and response to triiodothyronine augmentation in major depressive disorder Biol Psychiatry 63 1127 1134 18206856 10.1016/j.biopsych.2007.11.020 1:CAS:528:DC%2BD1cXmsFOjtLw%3D
42. FN Jacka S Overland R Stewart GS Tell I Bjelland A Mykletun 2009 Association between magnesium intake and depression and anxiety in community-dwelling adults: the Hordaland Health Study Aust N Z J Psychiatry 43 45 52 19085527 10.1080/00048670802534408
43. NL Johnston-Wilson CD Sims JP Hofmann L Anderson AD Shore EF Torrey RH Yolken 2000 Disease-specific alterations in frontal cortex brain proteins in schizophrenia, bipolar disorder, and major depressive disorder. The Stanley Neuropathology Consortium Mol Psychiatry 5 142 149 10822341 10.1038/sj.mp. 4000696 1:CAS:528:DC%2BD3cXlslartrg%3D (Pubitemid 30229428)
44. SU Kang K Fuchs W Sieghart A Pollak E Csaszar G Lubec 2009 Gel-based mass spectrometric analysis of a strongly hydrophobic GABAA-receptor subunit containing four transmembrane domains Nat Protoc 4 1093 1102 19707190 10.1038/nprot.2009.92 1:CAS:528:DC%2BD1MXovFSrt7w%3D
45. KM Kantak 1988 Magnesium deficiency alters aggressive behavior and catecholamine function Behav Neurosci 102 304 311 3365326 10.1037/0735-7044.102. 2.304 1:CAS:528:DyaL1cXkt1ajs7k%3D
46. JN Keller MS Kindy FW Holtsberg DK St Clair HC Yen A Germeyer SM Steiner AJ Bruce-Keller JB Hutchins MP Mattson 1998 Mitochondrial manganese superoxide dismutase prevents neural apoptosis and reduces ischemic brain injury: suppression of peroxynitrite production, lipid peroxidation, and mitochondrial dysfunction J Neurosci 18 687 697 9425011 1:CAS:528:DyaK1cXlsFajtw%3D%3D (Pubitemid 28041905)
47. N Kolla Z Wei JS Richardson XM Li 2005 Amitriptyline and fluoxetine protect PC12 cells from cell death induced by hydrogen peroxide J Psychiatry Neurosci 30 196 201 15944744 (Pubitemid 40942458)
48. SA Kromer MS Kessler D Milfay IN Birg M Bunck L Czibere M Panhuysen B Putz JM Deussing F Holsboer R Landgraf CW Turck 2005 Identification of glyoxalase-I as a protein marker in a mouse model of extremes in trait anxiety J Neurosci 25 4375 4384 15858064 10.1523/JNEUROSCI.0115-05.2005 (Pubitemid 40628782)
49. Levine J, Stein D, Rapoport A, Kurtzman L (1999) High serum and cerebrospinal fluid Ca/Mg ratio in recently hospitalized acutely depressed patients. Neuropsychobiology 39:63-70 (Pubitemid 29118952)
50. XM Li J Chlan-Fourney AV Juorio VL Bennett S Shrikhande RC Bowen 2000 Antidepressants upregulate messenger RNA levels of the neuroprotective enzyme superoxide dismutase (SOD1) J Psychiatry Neurosci 25 43 47 10721683 1:STN:280:DC%2BD3c7os1Clsw%3D%3D (Pubitemid 30143327)
51. V Libri R Santarelli S Nistico GB Azzena 1997 Inhibition of nitric oxide synthase prevents magnesium-free-induced epileptiform activity in guinea-pig piriform cortex neurones in vitro Naunyn Schmiedebergs Arch Pharmacol 355 452 456 9109360 10.1007/PL00004968 1:CAS:528:DyaK2sXitlCjsLg%3D (Pubitemid 27140566)
52. RJ MacAllister H Parry M Kimoto T Ogawa RJ Russell H Hodson GS Whitley P Vallance 1996 Regulation of nitric oxide synthesis by dimethylarginine dimethylaminohydrolase Br J Pharmacol 119 1533 1540 8982498 1:CAS:528: DyaK2sXkt1aqsg%3D%3D (Pubitemid 27019525)
53. IT Mak AM Komarov TL Wagner RE Stafford BF Dickens WB Weglicki 1996 Enhanced NO production during Mg deficiency and its role in mediating red blood cell glutathione loss Am J Physiol 271 C385 C390 8760069 1:CAS:528: DyaK28Xkslygt7g%3D (Pubitemid 26298815)
54. PJ Marangos AP Zis RL Clark FK Goodwin 1978 Neuronal, non-neuronal and hybrid forms of enolase in brain: structural, immunological and functional comparisons Brain Res 150 117 133 78744 10.1016/0006-8993(78)90657-1 1:CAS:528:DyaE1cXlsVansr4%3D (Pubitemid 8367979)
55. PJ Marangos DE Schmechel AM Parma FK Goodwin 1980 Developmental profile of neuron-specific (NSE) and non-neuronal (NNE) enolase Brain Res 190 185 193 6769532 10.1016/0006-8993(80)91168-3 1:CAS:528:DyaL3cXitFalur0%3D (Pubitemid 10085560)
56. TM Michel J Thome D Martin K Nara S Zwerina T Tatschner HG Weijers E Koutsilieri 2004 Cu, Zn- and Mn-superoxide dismutase levels in brains of patients with schizophrenic psychosis J Neural Transm 111 1191 1201 15338334 10.1007/s00702-004-0160-9 1:CAS:528:DC%2BD2cXntVaqtr8%3D (Pubitemid 39222778)
57. TM Michel S Frangou D Thiemeyer S Camara J Jecel K Nara A Brunklaus R Zoechling P Riederer 2007 Evidence for oxidative stress in the frontal cortex in patients with recurrent depressive disorder-a postmortem study Psychiatry Res 151 145 150 17296234 10.1016/j.psychres.2006.04.013 1:CAS:528: DC%2BD2sXkslektrc%3D (Pubitemid 46634625)
58. J Mu P Xie ZS Yang DL Yang FJ Lv TY Luo Y Li 2007 Neurogenesis and major depression: implications from proteomic analyses of hippocampal proteins in a rat depression model Neurosci Lett 416 252 256 17368938 10.1016/j.neulet.2007. 01.067 1:CAS:528:DC%2BD2sXjslSqtLk%3D (Pubitemid 46505186)
59. P Muigg U Hoelzl K Palfrader I Neumann A Wigger R Landgraf N Singewald 2007 Altered brain activation pattern associated with drug-induced attenuation of enhanced depression-like behavior in rats bred for high anxiety Biol Psychiatry 61 782 796 17224133 10.1016/j.biopsych.2006.08.035 1:CAS:528:DC%2BD2sXisVWhtbs%3D (Pubitemid 46330248)
60. H Murck 2002 Magnesium and affective disorders Nutr Neurosci 5 375 389 12509067 10.1080/1028415021000039194 1:CAS:528:DC%2BD3sXovFWisg%3D%3D (Pubitemid 35469537)
61. Muroyama A, Inaka M, Matsushima H, Sugino H, Marunaka Y, Mitsumoto Y (2009) Enhanced susceptibility to MPTP neurotoxicity in magnesium-deficient C57BL/6N mice. Neurosci Res 63:72-75
62. EJ Nestler 1998 Antidepressant treatments in the 21st century Biol Psychiatry 44 526 533 9787876 10.1016/S0006-3223(98)00095-X 1:CAS:528: DyaK1cXmvFWksL0%3D (Pubitemid 28496679)
63. FH Nielsen 2010 Magnesium, inflammation, and obesity in chronic disease Nutr Rev 68 333 340 20536778 10.1111/j.1753-4887.2010.00293.x
64. B Petit-Demouliere F Chenu M Bourin 2005 Forced swimming test in mice: a review of antidepressant activity Psychopharmacology (Berl) 177 245 255 10.1007/s00213-004-2048-7 1:CAS:528:DC%2BD2cXhtVyltLrE (Pubitemid 40137284)
65. I Petrault W Zimowska J Mathieu D Bayle E Rock A Favier Y Rayssiguier A Mazur 2002 Changes in gene expression in rat thymocytes identified by cDNA array support the occurrence of oxidative stress in early magnesium deficiency Biochim Biophys Acta 1586 92 98 11781153 1:CAS:528:DC%2BD38XitlSqtQ%3D%3D (Pubitemid 34066619)
66. E Poleszak B Szewczyk E Kedzierska P Wlaz A Pilc G Nowak 2004 Antidepressant- and anxiolytic-like activity of magnesium in mice Pharmacol Biochem Behav 78 7 12 15159129 10.1016/j.pbb.2004.01.006 1:CAS:528: DC%2BD2cXkt1Srs7k%3D (Pubitemid 38670508)
67. E Poleszak P Wlaz E Kedzierska D Nieoczym A Wrobel S Fidecka A Pilc G Nowak 2007 NMDA/glutamate mechanism of antidepressant-like action of magnesium in forced swim test in mice Pharmacol Biochem Behav 88 158 164 17825400 10.1016/j.pbb.2007.07.018 1:CAS:528:DC%2BD2sXhtFWht7%2FE (Pubitemid 350115999)
68. Rasmussen HH, Mortensen PB, Jensen IW (1989) Depression and magnesium deficiency. Int J Psychiatry Med 19:57-63 (Pubitemid 19137185)
69. Y Rayssiguier E Gueux L Bussiere J Durlach A Mazur 1993 Dietary magnesium affects susceptibility of lipoproteins and tissues to peroxidation in rats J Am Coll Nutr 12 133 137 8463512 1:CAS:528:DyaK3sXlsFyqs7k%3D (Pubitemid 23104366)
70. E Rock C Astier C Lab C Malpuech W Nowacki E Gueux A Mazur Y Rayssiguier 1995 Magnesium deficiency in rats induces a rise in plasma nitric oxide Magnes Res 8 237 242 8845288 1:CAS:528:DyaK28XhvFSrtL8%3D (Pubitemid 126000279)
71. HF Schimatschek R Rempis 2001 Prevalence of hypomagnesemia in an unselected German population of 16, 000 individuals Magnes Res 14 283 290 11794636 1:CAS:528:DC%2BD38XktlKitw%3D%3D (Pubitemid 33648227)
72. S Schuchmann D Albrecht U Heinemann O und Halbach 2002 Nitric oxide modulates low-Mg2+-induced epileptiform activity in rat hippocampal-entorhinal cortex slices Neurobiol Dis 11 96 105 12460549 10.1006/nbdi.2002.0533 1:CAS:528:DC%2BD38XovVyhtr0%3D (Pubitemid 35435677)
73. I Sillaber M Panhuysen MS Henniger F Ohl C Kuhne B Putz T Pohl JM Deussing M Paez-Pereda F Holsboer 2008 Profiling of behavioral changes and hippocampal gene expression in mice chronically treated with the SSRI paroxetine Psychopharmacology (Berl) 200 557 572 10.1007/s00213-008-1232-6 1:CAS:528:DC%2BD1cXhtFOjsbjE
74. N Singewald C Sinner A Hetzenauer SB Sartori H Murck 2004 Magnesium-deficient diet alters depression- and anxiety-related behavior in mice-influence of desipramine and Hypericum perforatum extract Neuropharmacology 47 1189 1197 15567428 1:CAS:528:DC%2BD2cXhtVahurfK (Pubitemid 39572710)
75. N Singewald SB Sartori JH Shin L Lin G Lubec N Whittle 2010 Magnesium- and zinc-deficiency models for depression: Involvement of NMDA/NO pathways Biol Psychiatry 67 689
76. Spasov AA, Iezhitsa IN, Kharitonova MV, Kravchenko MS (2008) Depression-like and anxiety-related behaviour of rats fed with magnesium-deficient diet. Zh Vyssh Nerv Deiat Im I P Pavlova 58:476-485
77. RE Stafford IT Mak JH Kramer WB Weglicki 1993 Protein oxidation in magnesium deficient rat brains and kidneys Biochem Biophys Res Commun 196 596 600 8240333 10.1006/bbrc.1993.2291 1:CAS:528:DyaK2cXmt1Ck (Pubitemid 23337649)
78. N Takei J Kondo K Nagaike K Ohsawa K Kato S Kohsaka 1991 Neuronal survival factor from bovine brain is identical to neuron-specific enolase J Neurochem 57 1178 1184 1895102 10.1111/j.1471-4159.1991.tb08277.x 1:CAS:528:DyaK3MXmslWntr4%3D (Pubitemid 21922739)
79. A Tschenett N Singewald M Carli C Balducci P Salchner A Vezzani H Herzog G Sperk 2003 Reduced anxiety and improved stress coping ability in mice lacking NPY-Y2 receptors Eur J Neurosci 18 143 148 12859347 10.1046/j.1460-9568.2003. 02725.x (Pubitemid 36920855)
80. G Wegener V Volke BH Harvey R Rosenberg 2003 Local, but not systemic, administration of serotonergic antidepressants decreases hippocampal nitric oxide synthase activity Brain Res 959 128 134 12480166 10.1016/S0006-8993(02) 03738-1 1:CAS:528:DC%2BD38XptlWmtL0%3D (Pubitemid 35435413)
81. Wegener G, Harvey BH, Bonefeld B, Müller HK, Volke V, Overstreet DH, Elfving B (2010) Increased stress-evoked nitric oxide signalling in the Flinders sensitive line (FSL) rat: a genetic animal model of depression. Int J Neuropsychopharmacol 13:461-473
82. R Weitzdorfer H Hoger G Burda A Pollak G Lubec 2008 Differences in hippocampal protein expression at 3 days, 3 weeks, and 3 months following induction of perinatal asphyxia in the rat J Proteome Res 7 1945 1952 18355016 10.1021/pr700835y 1:CAS:528:DC%2BD1cXjsFyruro%3D
83. N Whittle G Lubec N Singewald 2009 Zinc deficiency induces enhanced depression-like behaviour and altered limbic activation reversed by antidepressant treatment in mice Amino Acids 36 147 158 18975044 10.1007/s00726-008-0195-6 1:CAS:528:DC%2BD1MXht12nsg%3D%3D
84. G Wu 2009 Amino acids: metabolism, functions, and nutrition Amino Acids 37 1 17 19301095 10.1007/s00726-009-0269-0
85. G Wu TE Haynes H Li W Yan CJ Meininger 2001 Glutamine metabolism to glucosamine is necessary for glutamine inhibition of endothelial nitric oxide synthesis Biochem J 353 245 252 11139387 10.1042/0264-6021:3530245 1:CAS:528:DC%2BD3MXotFWnsg%3D%3D (Pubitemid 32096932)
86. G Wu FW Bazer TA Davis SW Kim P Li J Marc Rhoads M Carey Satterfield SB Smith TE Spencer Y Yin 2009 Arginine metabolism and nutrition in growth, health and disease Amino Acids 37 153 168 19030957 10.1007/s00726-008-0210-y 1:CAS:528:DC%2BD1MXltlemtL0%3D
87. A Zafir N Banu 2007 Antioxidant potential of fluoxetine in comparison to Curcuma longa in restraint-stressed rats Eur J Pharmacol 572 23 31 17610875 10.1016/j.ejphar.2007.05.062 1:CAS:528:DC%2BD2sXhtVCitrbL (Pubitemid 47374675)
88. A Zafir A Ara N Banu 2009 Invivo antioxidant status: a putative target of antidepressant action Prog Neuropsychopharmacol Biol Psychiatry 33 220 228 19059298 10.1016/j.pnpbp.2008.11.010 1:CAS:528:DC%2BD1MXit1Wqtbo%3D
89. J Zheng SS Patil WQ Chen W An J He H Hoger G Lubec 2009 Hippocampal protein levels related to spatial memory are different in the Barnes maze and in the Multiple T-maze J Proteome Res 8 4479 4486 19650667 10.1021/pr9002596 1:CAS:528:DC%2BD1MXpvV2nt7k%3D